The small interfering RNA-mediated knockdown of Capn4 expression in HCC cell lines significantly inhibited its invasive ability, and Capn4 overexpression might be a biomarker for diagnosing HCC and a target for therapy [11]. This evidence concerns the gene CAPNS1 and hepatocellular carcinoma.